Merrimack Pharmaceuticals Inc
MACK
Revenue
61.24M
▲33.17M▲118.16%
3 Months ChangeAssets
244.32M
▲225.13M▲1173.31%
3 Months ChangeLiabilities
22.67M
▲22.23M▲5041.04%
3 Months ChangeFree Cash Flow
-17.36M
▼-6.91M▼-66.14%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-05-15
Form 10-Q
ID: 0000950170-24-060478
2024-05-10
Form 8-K
ID: 0001193125-24-136237
2024-05-09
Form 8-K
ID: 0001193125-24-134773
2024-04-30
Form 8-K
ID: 0001193125-24-125367
2024-03-27
Form 8-K
ID: 0001193125-24-078910
2024-03-07
Form 8-K
ID: 0001193125-24-062260
2024-02-13
Form 8-K
ID: 0001193125-24-033761
2023-11-02
Form 8-K
ID: 0001193125-23-269425
2023-11-02
Form 10-Q
ID: 0000950170-23-058273
2023-08-03
Form 8-K
ID: 0001193125-23-202917